Particle Sciences has added new coating capabilities for preparing polymer film-based drug products from liquid formulations, under cGMPs. The company focuses on advanced drug delivery solutions and is FDA registered and licensed for all schedules of controlled substances.
Garry Gwozdz, director of Formulation Services, said, “Particle Sciences’ purpose is to provide our clients with the most efficient drug product. Increasingly, we are seeing a demand for thin film-based products, particularly with respect to transdermal drug-eluting patch products, and rapidly-dissolving strips. While we have been working in this area for some time, the acquisition of semi-automated coating equipment will allow us to screen more formulation approaches, and get our clients into the clinic faster with a commercially representative film-based product.”
Mr. Gwozdz added, “Particle Sciences already had cGMP hot-melt film extrusion capability and now with the addition of coating and drying capabilities for liquid-based formulations, our clients have access to a complete array of viable and scalable film-manufacturing technologies.”